https://pittplusme.org/study/1790
Sweat Chloride Study – Ages 18-21
STUDY BASICS
Are you aged 18-21 and do not take medication for attention deficit-hyperactivity disorder (ADHD)? If so, you may be able to participate in a 1-visit research study to help compare salt levels in sweat (called sweat chloride levels) in people who do and do not take ADHD medications. Compensation provided and parking will be validated.
STUDY PURPOSE
High salt levels in sweat (called sweat chloride levels) can be an indication of disease but may also be caused by certain medications. The purpose of this study is to examine sweat chloride levels in young adults who do and do not take prescription medications used to treat attention deficit-hyperactivity disorder (ADHD). Researchers hope their findings lead to a better understanding of the effects of ADHD medications on sweat chloride levels and on overall sweat volume in general.
COULD THIS STUDY BE RIGHT FOR YOU?
- Ages 18-21
- Do not take ADHD medication
WHAT PARTICIPANTS CAN EXPECT
This study involves one in-person visit that will last about 1.5 hours. Participation includes completing questionnaires and having sweat collected. Sweat collection involves attaching a small device and an electrode to your arm or leg, which allows the technician to apply a weak electrical current to stimulate sweating.
IRB: STUDY20040356C
- Measurement of Sweat Chloride Levels in Patients Receiving Medications for Attention Deficit Disorder
MEET THE RESEARCHER
Daniel Weiner
Daniel Weiner, MD, is Professor of Pediatrics at the University of Pittsburgh School of Medicine. Dr. Weiner serves as the Medical Director of the Pulmonary Function Laboratory and the Co-Director of the Cystic Fibrosis Center, both of which are located at Children’s Hospital of Pittsburgh. Dr. Weiner specializes in research on genetic and congenital conditions that can impact the lungs, like muscular dystrophy or cystic fibrosis.